PBM

NASD Psyence Biomedical Ltd.
Oct 2, 2026 · 4:04 PM ET LAST TRADE Market Closed

$5.16 ↓ -0.32 (-5.84%) Trading Down from the previous close of $5.48, $0.47 below the day’s high of $5.63

YTD change
-82.47%
vs 20-day SMA
-7.97%
vs 200-day SMA
-35.10%

Price ranges

Previous day
$5.40 $5.70
open $5.42 close $5.48
+$0.06 (+1.11%)
Today
$5.12 $5.63
open $5.52 now $5.16
-$0.36 (-6.52%)
Past week
$5.38 $5.96
from $5.86 now $5.16
-$0.70 (-11.95%)
Past month
$4.26 $7.19
from $4.37 now $5.16
+$0.79 (+18.08%)
This year
$0.61 $29.43
from $29.43 now $5.16
-$24.27 (-82.47%)

Price & Performance

+3.01 (+121.86%) / 6M

$1.76$5.18$8.59$12.01Apr 2Jul 2Oct 1

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 100.0% away from all-time highs of $100,637.00
  • PBM is down 82% since the beginning of the year
  • PBM is down 96% over the past 12 months
  • PBM is up 18% over the past 1 month
  • 2% of all PBM investors are betting against PBM

PBM reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +66.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $-4465450.0
Beta 4.54

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$7.5M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $27.4M

Psyence Biomedical Ltd. is a holding company, which engages in the development and commercialization of pharmaceutical products in neurology. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company was founded on February 25, 2021 and is headquartered in Toronto, Canada.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,149.85 -0.62%
JNJ Johnson & Johnson $258.66 -2.30%
ABBV AbbVie, Inc. $259.93 -0.63%
MRK Merck & Co., Inc. $143.81 -1.03%
RHHVF Roche Holding Ltd $442.60 +6.66%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.